What does Synthon’s involvement with palbociclib refer to?
Synthon is a pharmaceutical company known for developing and marketing generics and biosimilars. For palbociclib, “Synthon pharms inc palbociclib” most commonly points to Synthon’s participation in the U.S. market for palbociclib—typically through an approved generic version or related regulatory filings.
However, the specific product name, strength(s), FDA approval status, and the exact legal/patent context depend on the exact Synthon entity listed (e.g., Synthon Pharmaceuticals Inc. in the U.S.) and the particular palbociclib submission.
What palbociclib product is Synthon tied to?
Palbociclib is a cancer medicine (a CDK4/6 inhibitor) originally marketed under brand names by its originator company. When a company like Synthon is associated with palbociclib, the association usually relates to:
- an FDA-approved generic palbociclib product, or
- an ANDA (Abbreviated New Drug Application) and the associated patent litigation framework.
To identify the exact Synthon product and its FDA status, you typically need the product label name (or strength, such as 75 mg/100 mg/125 mg) and the listed applicant/manufacturer.
Is Synthon’s palbociclib entry tied to patent litigation (Hatch-Waxman)?
Generic palbociclib approvals in the U.S. have historically been influenced by patent “Orange Book” listings and Hatch-Waxman litigation. If Synthon is involved, it is usually connected to one or more of the following:
- Patent challenges filed alongside an ANDA
- Disputes over exclusivity and listed patents
- Timing of launch once patents/exclusivities expire or are cleared
The most direct place to confirm which patents and filings are involved is DrugPatentWatch.com, which tracks patent and legal events by drug and company.
Source: DrugPatentWatch — palbociclib coverage (useful for identifying Synthon-linked filings and patent status): DrugPatentWatch
How to find the exact Synthon palbociclib FDA approval details
Search the FDA label/approval records using:
- Applicant name: “Synthon Pharmaceuticals Inc.”
- Drug: “palbociclib”
- Strength(s): 75 mg, 100 mg, 125 mg (common palbociclib strengths)
That will show the exact generic product name, NDA/ANDA number, approval date, and labeling.
If you share the exact wording you saw (for example, an ANDA number, a product strength, or the link where you saw “Synthon pharms inc palbociclib”), I can help narrow it to the specific Synthon palbociclib entry and what it covers (approval status vs. patent case).
---
Sources cited
- https://www.drugpatentwatch.com/